ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

Dose-response efficacy and safety of the aldosterone synthase inhibitor baxdrostat in resistant hypertension: a systematic review and network meta-analysis.

Muhammad Shahzaib et al.PubMed ↗Publisher ↗

No numbers read from the abstract.